| Cardiorenal Actions of Trevena Biased Ligand Heart Failure Drug Explained in ... - MarketWatch (press release) |
|
|
MarketWatch (press release) The data published this month in Circulation:Heart Failure shows that TRV027 rapidly and reversibly corrects hemodynamic parameters altered in paced heart failure canines, including both vascular and cardiac measures, while preserving renal function. |